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a  b  s  t  r  a  c  t
Manganese  (Mn)  is an  essential  metal  commonly  found  in the  environment  and  is used
for  industrial  purposes.  Exposure  to excessively  high  Mn  levels  may  induce  neurotoxicity
referred  to as manganism.  This  work  was  conducted  to study  the  effect  of  manganese  on the
olfactory  bulb  of adult  male albino  rat  and  the  possible  protective  role  of  meloxicam.  Forty
adult male  albino  rats  were  equally  divided  into  four  groups:  control  group,  meloxicam-
treated  group  (5  mg/kg/day  orally  for 4  weeks),  MnCl2-treated  group  (10  mg/kg/day  orally
for 4 weeks),  and  the  fourth  group  received  both  meloxicam  and  MnCl2 at the  same
doses  and  duration.  Specimens  of  the  olfactory  bulbs  were  prepared  for light  and  elec-
tron  microscopy.  An  immunohistochemical  study  with  a quantitative  morphometry  was
performed using  antibodies  against  glial  ﬁbrillary  acidic  protein  (GFAP).  The  control  group
and  meloxicam-treated  group  showed  the  same  normal  structure.  MnCl2-treated  group
showed shrinkage  of  mitral  nerve  cells  with  dark peripheral  nuclei  as  well  as  disorganiza-
tion  of mitral  and  granule  nerve  cells.  The  surrounding  neuropil  showed  vacuolar  spaces.
Ultrastructurally,  the  mitral  cells  showed  accumulation  of  lysosomes,  swelling  of  mitochon-
dria and  irregularity  of  the  nuclei.  The  nerve  ﬁbers  contained  swollen  mitochondria  with
splitting  and  irregularity  of the  surrounding  myelin  sheaths.  GFAP  immunoreaction  showed
a highly  signiﬁcant  increase  compared  to control  group.  On  the  other  hand,  the  group  that
received  both  meloxicam  and  MnCl2 showed  less  marked  histological  changes.  It  was  con-
cluded  that  manganese  induced  structural  changes  in  the  olfactory  bulb  of  albino  rat that
were ameliorated  by concomitant  use  of  meloxicam.
© 2014  Saudi  Society  of  Microscopes.  Published  by Elsevier  Ltd.  All  rights  reserved.1. Introduction
Manganese (Mn) is a naturally occurring trace ele-
ment, critical for optimal functions of different organs [1].
It  participates in numerous enzymatic reactions such as
hydrolases, kinases, decarboxylases and transferases. In
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2213-879X/© 2014 Saudi Society of Microscopes. Published by Elsevier Ltd. All riaddition, it acts as a co-factor for a series of enzymes
involved in both lipid and carbohydrate metabolism [2,3].
Deﬁciency or excessive exposure to this metal may  lead to
various  health disorders [4].
Environmental contamination by Mn  may  occur as a
result  of its use for industrial purposes including the man-
ufacture of steel, iron, glass ceramics and fertilizers [5]. It is
also  used in the manufacture of paints, soaps, batteries and
insecticides. Both mine and metal workers are frequently
exposed to Mn  [6]. Increased levels of Mn  have been also
ghts reserved.
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etected in individuals ingesting contaminated well-water
nd  parenteral nutrition therapy [7]. These environmental,
ccupational and disease conditions lead to excessive Mn
ccumulation in the nervous system [8]. It was recorded
hat Mn  may  cause intoxication in humans exposed to high
oncentrations of this metal or to low doses for long periods
f  time [9].
The  pulmonary route is the main entrance of Mn  into
he  body. However, the brain can retain it for longer periods
f  time than other organs, probably due to its inability to
et  rid of the excess of this metal. Manganese may  cross
he  blood brain barrier and is delivered to different brain
egions via an axonal transport system [6]. It was  reported
hat  exposure to high levels of Mn  may  cause an irreversible
rain disease referred to as manganism, with symptoms
imilar to those in Parkinson’s disease [10].
Several antioxidants have been reported to reduce
he oxidative stress occurring during neurotoxicity. Non-
teroidal anti-inﬂammatory drugs (NSAIDs) are the group
f  drugs with anti-inﬂammatory, analgesic and antipyretic
ctivities that work by interfering with the cyclooxy-
enase (COX) pathway. They inhibit the enzyme COX
hich is responsible for converting arachidonic acid into
rostaglandin H2 which is a mediator of inﬂammation [11].
SAIDs  have an antioxidant property and have been shown
o  improve the circulating antioxidant status in different
iseases [12–14].
Meloxicam is a NSAID that appears to have a selec-
ive inhibitory activity against the inducible isoform
yclooxygenase-2 (COX-2), than against the constitutive
soform cyclooxygenase-1 (COX-1). It was found that
nhibition of COX-1 is associated with gastrointestinal,
enal, and platelet aggregation adverse effects. Therefore,
eloxicam and other COX-2 selective inhibitors are pro-
oted  for their safer proﬁle of side effects. They reduce
rostaglandin biosynthesis without interference to the
ame  extent with the normal functions and mucosal
rotective activities mediated by COX-1 [11]. Moreover,
eloxicam has a signiﬁcant antioxidant role that has
een  reported in aluminum-induced oxidative stress in rat
rain  [14].
The  olfactory bulb is one of the structures located in the
imbic  region of the brain. It is an oval mass that lies below
he  anterior end of the olfactory sulcus. The olfactory bulb
s  supported and protected by the cribriform plate of the
thmoid bone, which in mammals separates it from the
lfactory epithelium, and which is perforated by olfactory
erve axons. The olfactory bulb consists of a collection of
erve  cells that receives impulses from the olfactory nerves
f  the nasal mucosa and continues as the olfactory tract
15].
This  research was designed to study the effect of man-
anese chloride (MnCl2) on the structure of olfactory
ulb of adult male albino rat and the possible role of
eloxicam as a protective agent against MnCl2 neuro-
oxicity using light and electron microscopes. In addition,
n  immunohistochemical technique was also performed
sing antibodies against glial ﬁbrillary acidic protein
GFAP) which is an intermediate ﬁlament protein found in
he  cytoskeleton of astrocytes and was used as a marker for
strogliosis [16].py and Ultrastructure 3 (2015) 8–18 9
2.  Materials and methods
The  present work was  carried out on 40 adult male
albino rats weighing 180–200 g each. They were housed
in  clean properly ventilated cages, maintained on a 12:12-
h  dark–light cycle and provided with balanced food and
water.  The animals were acclimatized for 10 days before
the  beginning of the experiment and the general condi-
tion  of the animals was checked daily. They were randomly
distributed into four groups (10 animals each):
Group I (control group): the animals were divided into
two subgroups: ﬁve rats were left without treatment and
ﬁve rats each was given 1 ml  of sterile saline each, orally
by a gastric tube once daily for 4 weeks.
Group II: each animal was  given meloxicam (5 mg/kg body
weight) [14] dissolved in 1 ml  of sterile saline orally by
a gastric tube once daily for 4 weeks. Meloxicam (Anti-
Cox II) was manufactured by ADWIA Company (10th of
Ramadan City, Egypt) in the form of tablets containing
15 mg  each.
Group  III: each animal was given MnCl2 (10 mg/kg body
weight) [3,17] dissolved in 1 ml  of sterile saline orally by a
gastric tube once daily for 4 weeks. MnCl2 was purchased
from El-Faraana Chemical Company (Tanta, Egypt) in the
form of a powder.
Group  IV: the animals were concomitantly given both
meloxicam and MnCl2 at the same doses and duration as
in groups II and III.
At the end of the experiment, all animals were
anesthetized by intraperitoneal injection of sodium pento-
barbital  (30 mg/kg body weight) [18]. Following perfusion
through the left ventricle of the heart with a ﬁxative con-
taining 2.5% glutaraldehyde and 4% paraformaldehyde in
0.1  M phosphate buffer at pH 7.4, the brains were imme-
diately extracted, and the olfactory bulbs were dissected
out.
For  light microscopy, the specimens were ﬁxed in 10%
neutral-buffered formalin, dehydrated through ascending
grades of ethanol, cleared in xylene and inﬁltrated and
embedded in parafﬁn wax. Then, sections (5 m thick)
were cut and stained with hematoxylin and eosin (H&E)
[19].
For  immunohistochemistry,  GFAP was performed on
formalin-ﬁxed parafﬁn-embedded specimens. The tissue
sections  were deparafﬁnized, rehydrated and incubated
for  30 min  with 3% hydrogen peroxide for inhibition of
endogenous peroxidase. The slides were rinsed in phos-
phate  buffered saline (PBS) and incubated overnight at
4 ◦C with anti-GFAP antibody (NeoMarkers/Lab Vision, Fre-
mont,  CA, USA). Sections were then rinsed in PBS, incubated
for  1 h with biotinylated peroxidase-conjugated secondary
antibody. In the next step, sections were rinsed in PBS and
incubated with diaminobenzidine (DAB) for visualization
of the immunoreaction. The sections were then rinsed in
PBS,  counterstained with Mayer’s hematoxylin, dehydrated
and  mounted. The negative control sections were incu-
bated  with normal serum instead of the primary antibody,
while other steps of the procedure were the same [20,21].
icroscopy and Ultrastructure 3 (2015) 8–18
Fig. 1. A photomicrograph of a section in the olfactory bulb from the con-
trol group showing six laminae: olfactory nerve layer (1), glomerular layer
(2),  external plexiform layer (3), mitral cell layer (4), internal plexiform
layer (5), and granular cell layer (6) (H&E, Mic. Mag. 200×).
Fig. 2. A photomicrograph of a section in the olfactory bulb from the con-
trol group showing pyramidal shaped mitral nerve cells with abundant
cytoplasm and vesicular nuclei (→). The granule nerve cells are rounded
small cells with scanty cytoplasm and dark nuclei (>). The granule cells
appear in clusters (—>) and some are scattered through the mitral cell
layer (H&E, Mic. Mag. 400×).10 A.M. Mousa, A.A. Shehab / Journal of M
For electron microscopy, the specimens were immersed
for 2 h in 2.5% phosphate buffered glutaraldehyde solu-
tion  (pH 7.4) at 4 ◦C. After washing with phosphate buffer,
the  specimens were post-ﬁxed for 1 h in 1% buffered
osmium tetroxide solution. Subsequently, the specimens
were dehydrated and cleared in acetone and were embed-
ded  in epoxy resin. Semithin sections (1 m)  were stained
by  1% toluidine blue for proper orientation. Ultrathin sec-
tions  (70 nm)  were cut with a diamond knife on a LEICA
ultratome (Austria), double-stained with uranyl acetate
and  lead citrate [22], and were examined with a JEOL
electron microscope (Tokyo, Japan) at EM unit, Tanta Uni-
versity.
2.1.  Quantitative morphometric study
Regarding GFAP immunoreactivity, 10 different ﬁelds
were  randomly examined from each animal at a magniﬁca-
tion  of 400 and the area percentage of the immunoreaction
was measured using an image analyzer computer system.
All  quantitative data were expressed as means
(X) ± standard deviation (SD). Statistical analysis using Stu-
dent’s  t-test was carried out to compare each group with
the  control group. P value was calculated using Statistical
Package for Social Sciences (SPSS, version 11.5, Chicago,
USA) statistical analysis software. The results were consid-
ered  statistically signiﬁcant when P value was less than 0.05
and  highly signiﬁcant when P value was less than 0.001.
3.  Results
3.1. Light microscopic results
H&E-stained sections of the olfactory bulb obtained
from the control group (group I) showed normal six
laminae from outside inwards: olfactory nerve layer,
glomerular layer, external plexiform layer, mitral cell
layer,  internal plexiform layer and granular cell layer.
The olfactory nerve layer contained nerve ﬁbers and scat-
tered  supporting cells. In the glomerular layer, glomeruli
were observed; each of them was surrounded by a
rim  of periglomerular cells. The external plexiform layer
consisted of nerve ﬁbers and some neurons having dark
nuclei  (Fig. 1). The mitral cell layer showed pyramidal
shaped mitral nerve cells having abundant cytoplasm and
pale  vesicular nuclei with prominent nucleoli. Some gran-
ule  nerve cells were observed scattered through the mitral
cell  layer. They appeared smaller than mitral cells with
scanty cytoplasm and dark nuclei. The internal plexiform
layer was adjacent to the mitral cell layer and consisting
mainly of nerve ﬁbers. In the granular cell layer, numer-
ous  granule nerve cells appeared in clusters. These granule
cells  were greater in number than any other type of cells
observed in the olfactory bulb (Figs. 2 and 3).
Regarding GFAP-immunostained sections, few cells
with  positive immunoreaction in their cytoplasmic pro-
cesses  were observed in different layers of the olfactory
bulb (Fig. 4).
It  was found that meloxicam-treated group (group II)
showed the same histological and immunohistochemical
ﬁndings as those of the control group.
Fig. 3. A photomicrograph of a section in the olfactory bulb from the
control group showing mitral nerve cells with abundant cytoplasm and
vesicular nuclei (→) containing prominent nucleoli. The granule nerve
cells are rounded small cells with scanty cytoplasm and dark nuclei (>).
Most of the granule cells appear in clusters (—>) (H&E, Mic. Mag. 1000×).
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Fig. 4. A photomicrograph of a section in the olfactory bulb from the con-
trol  group showing a few cells with positive immunoreaction in their
processes in different layers (→) (immunostaining for GFAP, Mic. Mag.
400×).
Fig. 5. A photomicrograph of a section in the olfactory bulb from MnCl2-
treated group (group III) showing disturbed architecture with loss of
normal laminar organization as well as vacuolar spaces in the neuropil
(*) (H&E, Mic. Mag  200×).
Fig. 6. A photomicrograph of a section in the olfactory bulb from group
III showing darkly stained mitral cells (→) with dark pyknotic peripheral
nuclei (>), disorganization of granular cell layer (–>) and vacuolar spaces
in  the neuropil (*) (H&E, Mic. Mag. 400×).
Fig. 7. A photomicrograph of a section in the olfactory bulb from group III
showing some mitral nerve cells with pyknotic nuclei (→) and some show
pericellular spaces (>). The neuropil shows vacuolar spaces (*) (H&E, Mic.
Mag.  1000×).
Fig. 8. A photomicrograph of a section in the olfactory bulb from group III
showing a strong extensive immunoreaction in the processes of astrocytes
in different layers (→) (immunostaining for GFAP, Mic. Mag. 400×).Fig. 9. A photomicrograph of a section in the olfactory bulb from
meloxicam and MnCl2-treated group (group IV) showing cytoplasmic vac-
uolation of some mitral nerve cells (→) (H&E, Mic. Mag. 400×).
As regards MnCl2-treated animals (group III), disturbed
architecture of the olfactory bulb was observed with loss
of  normal laminar organization (Fig. 5). The mitral nerve
cells  appeared distorted, small, and shrunken with darkly
12 A.M. Mousa, A.A. Shehab / Journal of Microscopy and Ultrastructure 3 (2015) 8–18
Fig. 10. A higher magniﬁcation of a part of the previous ﬁgure showing
cytoplasmic vacuolation of some mitral nerve cells (→) (H&E, Mic. Mag.
1000×).
Table 1
The  mean values of area percentage of GFAP immunoreaction (mean ± SD)
in  different groups and their relations.
Groups Area percentage of
GFAP
immunoreaction
P Signiﬁcance
Group I 1.32 ± 0.1
Group  II 1.37 ± 0.05 >0.05 Non-signiﬁcantFig. 11. A photomicrograph of a section in the olfactory bulb from group
IV showing a few cells with positive immunoreaction in their processes
in different layers (→) (immunostaining for GFAP, Mic. Mag. 400×).
stained cytoplasm and dark pyknotic peripheral nuclei
(Figs. 6 and 7). Pericellular spaces were also observed
around some mitral cells (Fig. 7). The granular cell layer
appeared disorganized with loss of normal arrangement of
the  granule nerve cells (Fig. 6). The surrounding neuropil
showed vacuolar spaces (Figs. 5–7).
GFAP-immunostained sections showed a strong exten-
sive  immunoreaction in the processes of astrocytes in
different layers of the olfactory bulb (Fig. 8).
In animals treated with both meloxicam and MnCl2
(group IV), mild structural changes were occasionally
observed in some specimens such as cytoplasmic vacuola-
tion  of some mitral nerve cells (Figs. 9 and 10). In addition,
few  cells with positive GFAP immunoreactions in their
cytoplasmic processes were observed in different layers
(Fig.  11).
3.2.  Electron microscopic results
Examination of ultrathin sections of the olfactory bulb
from  the control group showed normal mitral nerve cells
with  elongated perikaryon containing a central euchro-
matic nucleus and abundant cytoplasm containing RER,
free  ribosomes and mitochondria (Fig. 12). The granuleGroup  III 3.62 ± 0.2 <0.001 Highly signiﬁcant
Group IV 1.39 ± 0.01 >0.05 Non-signiﬁcant
nerve cells appeared smaller than mitral cells with scanty
cytoplasm and heterochromatic nuclei (Fig. 13). The sur-
rounding neuropil showed some unmyelinated nerve
ﬁbers and some myelinated axons with regular myelin
sheaths (Figs. 12 and 13).
Meloxicam-treated group (group II) showed more or
less  the same ultrastructural appearance as the control
group.
In  MnCl2-treated animals (group III), the mitral nerve
cells showed prominent ultrastructural alterations such
as  cytoplasmic vacuolation (Figs. 14 and 15), accumula-
tion of lysosomal dense bodies (Fig. 14), and swelling of
mitochondria with disruption of the cristae (Fig. 16). In
some  specimens, blebbing of the nuclear envelope was also
observed  (Fig. 15). Some cells contained shrunken irregular
nuclei  with dilatation of perinuclear space (Fig. 16). How-
ever,  the ultrastructural appearance of the granule nerve
cells  appeared more or less normal. Marked swelling
and irregularity of some nerve ﬁbers were also observed
(Figs. 15–17). Some axons contained swollen mitochondria
(Fig. 15) with splitting, corrugation and irregularity of the
surrounding myelin sheaths (Figs. 15–17).
In contrast, these ultrastructural changes were much
less pronounced in mitral nerve cells of group IV. The
majority of mitral nerve cells appeared containing normal
euchromatic nuclei, RER, free ribosomes and mitochondria.
However, some axons showed mild splitting of the myelin
sheath  (Fig. 18).
3.3.  Morphometric analysis
Regarding  GFAP immunoreaction, the mean value of
area  percentage of the positive reaction in group I (control
group) was  1.32 ± 0.1 and that of group II was  1.37 ± 0.05
with  a non-signiﬁcant difference (P > 0.05) between them.
The  mean value of area percentage of the positive reaction
in  group III was 3.62 ± 0.2 recording a highly signiﬁcant
increase (P < 0.001) when compared with the control group,
whereas  that of group IV was 1.39 ± 0.01 recording a non-
signiﬁcant increase (P > 0.05) when compared with the
control  group (Table 1).
4.  Discussion
The present work showed that administration of MnCl2
induced structural changes in the olfactory bulb of adult
albino rat in the form of loss of normal laminar organiza-
tion, distortion of mitral and granule nerve cells, shrinkage
of  mitral cells with darkly stained cytoplasm and dark
A.M. Mousa, A.A. Shehab / Journal of Microscopy and Ultrastructure 3 (2015) 8–18 13
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Mig. 12. An electron micrograph of the olfactory bulb from the control gr
ytoplasm  containing RER, free ribosomes (→) and mitochondria (—>). T
heaths  (>) (Mic. Mag. 14,600×).
yknotic peripheral nuclei as well as pericellular spaces
nd  vacuolar spaces in the surrounding neuropil.
Several studies have shown that the olfactory bulb is
ne  of the brain regions with the highest Mn  concentration
23,24]. It represents an important route for Mn  transport,
torage, and release in the brain, via a retrograde mech-
nism [25]. It has been shown that Mn  may  be taken by
he  olfactory neurons, released near their terminals, and
s  then transported to the olfactory cortex [26]. Another
esearch has also demonstrated bilateral trans-synaptic Mn
ransport  to other neurons of the olfactory system [27].
he  connections of olfactory bulb with the brain limbic
egion suggested the possibility that in humans, the initial
ig. 13. An electron micrograph of the olfactory bulb from the control group sho
ucleus (N). The surrounding neuropil contains some unmyelinated nerve ﬁbers
ag.  14,600×).wing a mitral nerve cell with an euchromatic nucleus (N) and abundant
ounding neuropil contains some myelinated axons with regular myelin
psychiatric symptoms of Mn  poisoning may  originate in the
olfactory–limbic pathway [28,29].
It was reported that Mn  exerts various effects at multi-
ple  sites within the central and peripheral nervous systems
[30].  It disturbs the functions of basal ganglia as well as cor-
tical  brain regions, such as the hippocampus, frontal cortex
and  parietal cortex. Within the peripheral nervous system,
Mn  exerts its effect on motor nerves and neuromuscu-
lar junctions [3]. Mn  was  also shown to induce neuronal
degeneration of caudate nucleus, putamen, globus pallidus,
cerebellum and substantia nigra along with morphological
alterations in the neurons from frontal cortex, hippocam-
pus, midbrain and pons [31].
wing a granule nerve cell with scanty cytoplasm and a heterochromatic
 (→) and some myelinated axons with regular myelin sheaths (>) (Mic.
14 A.M. Mousa, A.A. Shehab / Journal of Microscopy and Ultrastructure 3 (2015) 8–18
 group Fig. 14. An electron micrograph of the olfactory bulb from MnCl2-treated
and  lysosomal dense bodies (>) (Mic. Mag. 14,600×).
Both in vivo and in vitro experiments suggested that
oxidative stress and neuroinﬂammation are key mediators
of  Mn-induced neurodegeneration [32,33].
Regarding oxidative stress, it was found that the olfac-
tory  bulb is highly affected by chronic exposure to Mn  as
it  is very sensitive to the oxidative stress induced by ele-
vated  concentrations of this metal [28,29]. Several studies
indicated that oxidative stress, as an outcome of reactive
oxygen species (ROS) accumulation, plays a major role in
Mn-induced neurotoxicity. It was suggested that two  possi-
ble  mechanisms may  lead to oxidative stress: interference
with normal mitochondrial respiration and/or oxidation of
dopamine  and other catecholamines [32,34,35].
Fig. 15. An electron micrograph of the olfactory bulb from group III showing a m
envelope  (*). The surrounding neuropil contains swollen irregular axons that con
(>)  (Mic. Mag. 17,500×).(group III) showing a mitral nerve cell with cytoplasmic vacuolation (→)
It is known that glutathione (GSH) is critical for pro-
tecting the cells from oxidative stress because it functions
directly in reducing hydrogen peroxide and lipid peroxide
levels [36]. Signiﬁcant reduction in GSH levels has been
observed in rat brain after exposure to Mn  [17].
The other possible mechanism for Mn-induced neu-
rodegeneration was  neuroinﬂammation which was con-
sidered  as a neurodegenerative disease characterized by
increased  prostaglandin (PGE2) levels [37]. In vitro studies
have  established the release of pro-inﬂammatory medi-
ators  in response to Mn  [32]. Similarly, in mice exposed
to  Mn  in vivo, levels of neuroinﬂammatory mediators and
brain  prostaglandins (PGEs) were increased [33].
itral nerve cell with cytoplasmic vacuolation (→) and blebbing of nuclear
tain swollen mitochondria (—>) with corrugation of the myelin sheaths
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ristae  (→) and the other shows a shrunken irregular nucleus (N) with
rregular  axons (*) with splitting and irregularity of the myelin sheaths (—
In inﬂammatory conditions, the two enzymes that
ontribute to PGE2 production are cyclo-oxygenase-2
COX-2) and microsomal PGE2 synthase-1 [37]. The
nvolvement of these two enzymes in neurodegenera-
ive diseases has been extensively demonstrated [38,39].
he  cyclo-oxygenase-catalyzed reactions characteristic of
nﬂammatory responses also produces ROS. Accordingly,
 relationship exists between changes in biomarkers of
xidative damage and biomarkers of neuroinﬂammation
32].
The present work also showed ultrastructural alter-
tions in the mitral nerve cells of MnCl2-treated rats
uch as cytoplasmic vacuolation, lysosomal dense bodies,
ig. 17. An electron micrograph of the olfactory bulb from group III showing mar
rregularity  of the surrounding myelin sheaths (>) (Mic. Mag. 23,400×).o mitral nerve cells: one contains swollen mitochondria with disrupted
on of perinuclear space (>). The surrounding neuropil contains swollen
. Mag. 14,600×).
swelling  of mitochondria with disruption of the cristae as
well  as nuclear changes such as shrinkage and irregularity
of  the nuclei with dilatation of perinuclear space and
blebbing of the nuclear envelope. These observations
come in agreement with the ﬁndings of previous stud-
ies  that showed degenerated neurons with disorganization
of cytoplasmic components and swelling of mitochon-
dria in Mn-treated mice [6]. These ﬁndings were also
similar to those observed by other investigators in the
neurons of rat cerebral cortex after treatment with Mn,
including cytoplasmic vacuolation, swollen mitochondria,
dilated RER and Golgi apparatus as well as accumulated
lysosomes [40].
ked swelling and irregularity of some nerve axons (→) with splitting and
16 A.M. Mousa, A.A. Shehab / Journal of Microscopy and Ultrastructure 3 (2015) 8–18
 MnCl2-
 axons sFig. 18. An electron micrograph of the olfactory bulb from meloxicam and
nucleus  (N), normal RER (→), free ribosomes and mitochondria (>). Some
The cytoplasmic vacuoles observed in this study could
be  attributed to affection of the ﬂuidity of the cell mem-
brane by Mn  [41]. In addition, the important role of Mn
in  the regulation of the interaction between intracellular
membranes or vesicles and the cytoskeleton was suggested
[42].
It  was suggested that lysosomes could play an impor-
tant role in Mn  metabolism and the development of
this  metal toxicity [6]. It was also reported that Mn
is  accumulated in mitochondria and mitochondria-rich
tissues in vivo. Therefore, this organelle could play an
important role in the neurotoxicity of manganese [43].
Experimental evidence indicated that this metal caused
neuronal degeneration secondary to an alteration of the
oxidative energetic metabolism [6]. Changes in oxida-
tive  metabolism caused by Mn  have been linked to cell
apoptosis [44].
In  this work, marked swelling and irregularity of
nerve ﬁbers were also observed in the olfactory bulb of
MnCl2-treated animals. Some axons contained swollen
mitochondria with splitting, corrugation and irregularity
of  the surrounding myelin sheaths. These ﬁndings coin-
cided  with a previous study that showed alteration of the
periodic  pattern of myelin in Mn-treated mice [6]. Mito-
chondrial degeneration was also observed in the synapses
of  neurons in rat cerebral cortex after treatment with Mn
[40].
As  regards immunohistochemical results, the present
work showed a highly signiﬁcant increase in the area per-
centage  of GFAP immunoreaction that was observed in
the  cytoplasmic processes of astrocytes in different lay-
ers  of the olfactory bulb from MnCl2-treated animals. In
line  with this ﬁnding, astrocytosis as well as ultrastruc-
tural changes in the astrocytes were previously observed
in  the olfactory bulb of Mn-treated mice [6]. In addition,
an  increased astrocyte phagocytic activity associated with
ultrastructural changes in the astrocytes, oligodendrocytes
and microglia were previously reported in the caudatetreated group (group IV) showing a mitral nerve cell with an euchromatic
how mild splitting of the myelin sheath (—>) (Mic. Mag. 14,600×).
nucleus, substantia nigra and cerebral cortex of Mn-treated
rats [45].
It  was  reported that GFAP is an intermediate ﬁlament
protein found in the cytoskeleton of astroglia. It may  serve
as  a serum marker that is released after central nervous
system cell damage subsequent to astrogliosis [16].
It  was found that astrocytes respond to all forms of neu-
rodegenerative diseases by a process commonly referred
to  as reactive astrogliosis, which involves changes in
their  molecular expression, upregulation of GFAP, cellular
hypertrophy, proliferation and scar formation. Molecular
mediators of reactive astrogliosis can be released by differ-
ent  cell types in CNS tissue including neurons, microglia,
oligodendrocytes, endothelial cells, leukocytes and other
astrocytes, in response to CNS insults [46].
Several studies indicated that reactive astrocytes can
protect neuronal cells and tissue from oxidative stress via
glutathione production and by restricting the spread of
inﬂammation as well as stabilizing extracellular ﬂuid and
ion  balance. These ﬁndings indicate that reactive astrocytes
can  exert a range of essential neuroprotective and repair-
related functions in response to CNS insults of various
kinds. However, under certain circumstances, astrogliosis
can also lead to harmful effects through scar formation and
loss  of normal functions [47,48].
In animals concomitantly treated with both meloxi-
cam and MnCl2, mild structural changes were occasionally
observed in some specimens, such as cytoplasmic vacuo-
lation  of some mitral nerve cells and mild splitting of the
myelin  sheaths in some axons, indicating that meloxicam
could ameliorate the structural changes induced by MnCl2.
Several  anti-inﬂammatory agents have been found to
reduce  Mn  neurotoxicity [3]. This could be related to the
report  that the inﬂammatory processes play a role in the
pathogenesis of Mn-induced toxicity [32,33].
It was also shown that meloxicam has antioxidant like
properties as it reduced free oxygen radicals and lipid
peroxidation in the brain of aluminum-treated rats [14].
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t was also found to reduce oxygen radical generation in
at  gastric mucosa [49]. Although the exact mechanism of
ction  is unknown, many investigators have shown that
he  NSAIDs could eliminate the active oxygen species par-
icularly  superoxide anion [12]. Moreover, the circulating
uperoxide dismutase levels were improved with NSAID
reatment in rheumatoid arthritis [13].
Meloxicam has been reported to cross the blood brain
arrier [50]. Subsequently, it may  gain access to brain
arenchymal Mn  ions and directly decrease the bioavail-
bility of brain Mn  and its targeting sensitive sites [51].
In  conclusion, MnCl2 could induce structural changes in
he  olfactory bulb of adult albino rat. These changes could
e  partially minimized by concomitant administration of
eloxicam.
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